Three IPOs and two SPACs priced this week, and two SPACs submitted filings. City Therapeutics (CTY) priced its upsized IPO at the midpoint to raise $200 million at a $1.0 billion market cap. City Therapeutics is a Phase 1 biotech developing RNA interference...read more
TCGX Acquisition II, a blank check company formed by TCGX executives targeting healthcare in Asia, raised $100 million by offering 10 million shares at $10. Unlike most SPACs, the offering did not contain units with warrants or rights attached. TCGX...read more
One IPO and two SPACs debuted this week, although more deals were originally on the calendar. Five IPOs and three SPACs submitted initial filings. The biggest story in the IPO market this week may be the deals that didn’t get done. Homeowners insurance...read more
TCGX Acquisition II, a blank check company formed by TCGX executives targeting healthcare in Asia, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company plans to raise $100 million by offering 10 million units at...read more
US IPO Weekly Recap: Biotechs City Therapeutics and Iambic headline the week’s pricings
Three IPOs and two SPACs priced this week, and two SPACs submitted filings. City Therapeutics (CTY) priced its upsized IPO at the midpoint to raise $200 million at a $1.0 billion market cap. City Therapeutics is a Phase 1 biotech developing RNA interference...read more
SPAC TCGX Acquisition II prices $100 million IPO, targeting healthcare in Asia
TCGX Acquisition II, a blank check company formed by TCGX executives targeting healthcare in Asia, raised $100 million by offering 10 million shares at $10. Unlike most SPACs, the offering did not contain units with warrants or rights attached. TCGX...read more
US IPO Weekly Recap: Postponed deals put damper on fall IPO market
One IPO and two SPACs debuted this week, although more deals were originally on the calendar. Five IPOs and three SPACs submitted initial filings. The biggest story in the IPO market this week may be the deals that didn’t get done. Homeowners insurance...read more
SPAC TCGX Acquisition II files for a $100 million IPO, targeting healthcare in Asia
TCGX Acquisition II, a blank check company formed by TCGX executives targeting healthcare in Asia, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company plans to raise $100 million by offering 10 million units at...read more